<DOC>
	<DOC>NCT00004688</DOC>
	<brief_summary>OBJECTIVES: I. Assess the clinical response of patients with refractory or recurrent brain neoplasms treated with carmustine, streptozocin, and mercaptopurine.</brief_summary>
	<brief_title>Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms</brief_title>
	<detailed_description>PROTOCOL OUTLINE: Patients receive mercaptopurine IV on days 1-3, carmustine by continuous infusion on days 3-5, and streptozocin IV over 20 minutes on days 2-5. Patients receive treatment every 42 days, for up to 4 courses. Completion date provided represents the completion date of the grant per OOPD records</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Streptozocin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA: Disease Characteristics Histologically proven refractory or recurrent brain neoplasms Glioblastoma multiforme Anaplastic astrocytoma Gliosarcoma Anaplastic oligodendroglioma Mixed anaplastic glioma Unequivocally progressive primary brainstem tumors following primary therapy Measurable disease Prior/Concurrent Therapy Biologic therapy: Not specified Chemotherapy: At least 4 weeks since prior chemotherapy At least 6 weeks since prior nitrosoureas or mitomycin Endocrine therapy: Not specified Radiotherapy: Prior radiotherapy allowed Surgery: Prior surgery allowed Patient Characteristics Age: Not specified Performance status: ECOG 02 Karnofsky 60100% Hematopoietic: Granulocyte count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 2.0 mg/dL SGOT no greater than 4 times normal Renal: Creatinine no greater than 2.0 mg/dL Pulmonary: FEV1 greater than 1 L if symptomatic pulmonary disease present Other: No other concurrent malignancies Not pregnant or lactating Negative pregnancy test Fertile patients must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult brain tumor</keyword>
	<keyword>adult glioblastoma multiforme</keyword>
	<keyword>adult infiltrating astrocytoma</keyword>
	<keyword>brain tumor</keyword>
	<keyword>genetic condition</keyword>
	<keyword>miscellaneous sites/terms</keyword>
	<keyword>mixed gliomas</keyword>
	<keyword>nervous tissue tumors</keyword>
	<keyword>oncologic disorders</keyword>
	<keyword>rare disease</keyword>
	<keyword>recurrent adult brain tumor</keyword>
</DOC>